|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.3 NOK | -6.06% |
|
+2.88% | +91.36% |
| 05-30 | Transcript : Lytix Biopharma AS, Q1 2024 Earnings Call, May 30, 2024 | |
| 05-30 | Lytix Biopharma AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Lytix Biopharma AS reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was NOK 10.53 million. Revenue was NOK 10.53 million.
Net loss was NOK 18.18 million compared to NOK 19.67 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +91.36% | 43.49M | |
| +38.36% | 52.73B | |
| +36.73% | 39B | |
| -8.63% | 38.52B | |
| +25.46% | 30.38B | |
| -11.17% | 26.39B | |
| +11.44% | 26.08B | |
| +45.09% | 14.15B | |
| +32.93% | 12.6B | |
| -5.30% | 11.51B |
LYTIX BIOPHARMA 
